financetom
Business
financetom
/
Business
/
Databricks in talks to raise capital at $130 billion valuation, The Information reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Databricks in talks to raise capital at $130 billion valuation, The Information reports
Nov 17, 2025 6:48 PM

(Reuters) -Data analytics firm Databricks is in talks to raise funds at a valuation of more than $130 billion, about 30% higher than its last financing round two months ago, The Information reported on Monday, citing two people familiar with the discussion.

Reuters could not immediately confirm the report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mint Closes IPO to Raise $8.05 Million
Mint Closes IPO to Raise $8.05 Million
Jan 13, 2025
02:19 PM EST, 01/13/2025 (MT Newswires) -- Mint (MIMI), a Hong Kong-based interior design and fit-out works provider, said Monday it closed an initial public offering of Class A shares, raising $8.05 million in gross proceeds. The company sold around 2.01 million shares at $4 apiece, including 262,500 shares granted to underwriters for overallotments. Price: 4.37, Change: +0.26, Percent Change:...
Chainalysis Buys Israeli Fraud Detection Startup Alterya for $150M
Chainalysis Buys Israeli Fraud Detection Startup Alterya for $150M
Jan 13, 2025
Blockchain analytics company Chainalysis said Monday it had acquired fraud detection startup Alterya. The deal carried a price tag of $150 million, according to Business Insider. Chainalysis, the largest company tracing illicit crypto flows on behalf of financial institutions and governments, plans to bolster its scam-stopping capabilities with Alterya, CEO Jonathan Levin told CoinDesk. The two companies attack a thematically...
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
Biogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
Jan 13, 2025
Biogen Inc. ( BIIB ) submitted an unsolicited bid to acquire all of the outstanding shares of Sage Therapeutics Inc. ( SAGE ) that it does not already owned by Biogen for $7.22 per share. Goldman Sachs analyst Salveen Richter believes the proposal makes strategic sense, considering the financial success of the Zurzuvae launch for postpartum depression (PPD). Biogen says Zurzuvae exceeded its expectations. Also Read:...
Instacart, Uber Deal 'Makes More Sense Now,' Analyst Says: Here's Why
Instacart, Uber Deal 'Makes More Sense Now,' Analyst Says: Here's Why
Jan 13, 2025
Instacart parent company Maplebear Inc ( CART ) received an upgrade to Buy while also getting added to Needham’s conviction list on Monday as analysts expressed concern over increasing competition. What Happened: Needham analyst Bernie McTernan upgraded Maplebear ( CART ) from a Hold rating to a Buy rating. He also set a price target of $56, suggesting a nearly 30%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved